Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Jan 04, 2023 6:39pm
207 Views
Post# 35203858

RE:RE:RE:RE:Zack's

RE:RE:RE:RE:Zack'sThere is no Plan B with a checkmate, fuzzy. Rathjen, the BoD, Lind, LT and The Placee set this up so that a Plan B is impossible.

About being right, there is only one question and that is whether xB3 works or not. Of course LT and The Placee think it works and that it's worth a lot of money. That's why they made this deal. There is no other reason for players like this to put such an effort into a deal like this unless their 75% of the deal will make them a fortune. The question is whether they make their money solely on Biodexa or whether they make it on Biodexa and a spin-out of major xB3 properties to them. For me, there is no other reason to watch Biodexa that to see who gets sweet xB3 deals.

xB3 was always what the bet was all about. The failure with Bioasis is human and it is spectacular. It's just the type of failure that sharks look for and they sure did find it here.

Those of you pumping Biodexa are absolutely correct to do so. The problem, of course, is that the rightful owners of xB3 will only have 6% or so of it.

The market thinks very little of Midatech, no matter how much some people pump it on here. Poof's opinion runs completely in the face of the larger market, which when you get down to it, is how traders make money. 

jd
<< Previous
Bullboard Posts
Next >>